Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 05 Sep 2023

Prognostic and therapeutic implications of iron-related cell death pathways in acute myeloid leukemia

in Pharmacology of Anti-Cancer Drugs

Tongyu Li
Tongtong Lin
Jiahao Zhu
Miao Zhou
Shufang Fan
Hao Zhou
Qitian Mu
Lixia Sheng
Guifang Ouyang

Frontiers in Oncology

doi 10.3389/fonc.2023.1222098

2,889 views

Original Research

Published on 29 Aug 2023

Cell cycle arrest and apoptotic studies of Terminalia chebula against MCF-7 breast cancer cell line: an in vitro and in silico approach

in Pharmacology of Anti-Cancer Drugs

Pruthvish Reddy
Sushma Pradeep
Gopinath S. M.
Chandan Dharmashekar
Disha G.
Sai Chakith M. R.
Chandrashekar Srinivasa
Ali A. Shati
Mohammad Y. Alfaifi
Serag Eldin I. Elbehairi

Frontiers in Oncology

doi 10.3389/fonc.2023.1221275

4,962 views
2 citations

Original Research

Published on 28 Aug 2023

High quantum efficiency ruthenium coordination complex photosensitizer for improved radiation-activated Photodynamic Therapy

in Pharmacology of Anti-Cancer Drugs

Abul Kalam Azad
Lothar Lilge
Nawaid H. Usmani
John D. Lewis
Houston D. Cole
Colin G. Cameron
Sherri A. McFarland
Deepak Dinakaran
Ronald B. Moore

Frontiers in Oncology

doi 10.3389/fonc.2023.1244709

3,101 views
3 citations

Correction

Published on 25 Aug 2023

Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

in Pharmacology of Anti-Cancer Drugs

Daling Dong
Shixin Zhang
Bin Jiang
Wei Wei
Chao Wang
Qian Yang
Tingzhi Yan
Min Chen
Liken Zheng
Weikang Shao

Frontiers in Oncology

doi 10.3389/fonc.2023.1275851

1,251 views

Correction

Published on 25 Aug 2023

Corrigendum: Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

in Pharmacology of Anti-Cancer Drugs

Qian Zhao
Shan-Shan Xiong
Can Chen
Hong-Ping Zhu
Xin Xie
Cheng Peng
Gu He
Bo Han

Frontiers in Oncology

doi 10.3389/fonc.2023.1259550

1,238 views

Editorial

Published on 23 Aug 2023

Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches

in Pharmacology of Anti-Cancer Drugs

Manjari Singh
Manash K. Paul
Subhadeep Roy

Frontiers in Oncology

doi 10.3389/fonc.2023.1265523

1,273 views

Original Research

Published on 21 Aug 2023

COVID−19 hospitalization increases the risk of developing glioblastoma: a bidirectional Mendelian-randomization study

in Pharmacology of Anti-Cancer Drugs

Jiajun Dong
Shengnan Wang
Haoqun Xie
Yanhao Mou
Hao Zhu
Yilong Peng
Jianxin Xi
Minggu Zhong
Zhengyuan Xie
Zongyuan Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1185466

13,520 views
6 citations

Brief Research Report

Published on 14 Aug 2023

Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study

in Pharmacology of Anti-Cancer Drugs

Marilda Mormando
Edvina Galiè
Marta Bianchini
Rosa Lauretta
Giulia Puliani
Antonio Tanzilli
Umberto Anceschi
Giuseppe Simone
Gianluca Petreri
Giuliana Graziano

Frontiers in Oncology

doi 10.3389/fonc.2023.1222002

2,425 views
2 citations

Review

Published on 10 Aug 2023

A new approach to overcoming resistance to immunotherapy: nanotechnology

in Pharmacology of Anti-Cancer Drugs

Jiangbo Shao
Ying Jin
Chunxiang Jin

Frontiers in Oncology

doi 10.3389/fonc.2023.1210245

3,210 views
6 citations

Original Research

Published on 08 Aug 2023

CCDC43 as a potential therapeutic target of Tian Yang Wan for the treatment of hepatocellular carcinoma by activating the hippo pathway

in Pharmacology of Anti-Cancer Drugs

Mingyuan Tao
Dongwei Han
Siyu Wei
Changyu Gao

Frontiers in Oncology

doi 10.3389/fonc.2023.1232190

2,757 views
1 citation

Case Report

Published on 02 Aug 2023

Chemotherapy-induced toxic epidermal necrolysis in a patient with multiple myeloma, a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Rui X
Meidan W
Gongqiang W
Longyi Z
Xiaoxia W
Wei C
Chenhui W

Frontiers in Oncology

doi 10.3389/fonc.2023.1227448

3,542 views
3 citations

Review

Published on 31 Jul 2023

Targeting MCL-1 protein to treat cancer: opportunities and challenges

in Pharmacology of Anti-Cancer Drugs

Shady I. Tantawy
Natalia Timofeeva
Aloke Sarkar
Varsha Gandhi

Frontiers in Oncology

doi 10.3389/fonc.2023.1226289

13,400 views
38 citations

Original Research

Published on 26 Jul 2023

Preclinical PK investigation of a novel IDO1/TDO dual inhibitor—SHR9146 in mouse plasma and tissues by LC-MS/MS

in Pharmacology of Anti-Cancer Drugs

Mei Xiao
Kan Zhong
Li Guo
Wei Li
Xiaoli Wang
Zhenjun Qiu
Taijun Hang

Frontiers in Oncology

doi 10.3389/fonc.2023.1191778

2,132 views
2 citations

Opinion

Published on 24 Jul 2023

Tyrosine kinase inhibitors, ionic currents, and cardiac arrhythmia

in Pharmacology of Anti-Cancer Drugs

Chi-Hao Hu
Sheng-Nan Wu
Edmund Cheung So

Frontiers in Oncology

doi 10.3389/fonc.2023.1218821

2,318 views
4 citations

Original Research

Published on 21 Jul 2023

Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

in Pharmacology of Anti-Cancer Drugs

Daling Dong
Shixin Zhang
Bin Jiang
Wei Wei
Chao Wang
Qian Yang
Tingzhi Yan
Min Chen
Liken Zheng
Weikang Shao

Frontiers in Oncology

doi 10.3389/fonc.2023.1222716

4,019 views
3 citations

Systematic Review

Published on 20 Jul 2023

Efficacy and safety of metformin in combination with chemotherapy in cancer patients without diabetes: systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Kang Yang
Hao-hao Lu
Wei Zhao
Qingchun Zhao

Frontiers in Oncology

doi 10.3389/fonc.2023.1176885

2,630 views
9 citations